Evidence map›Paper›PMID 40917667›Full record

ArticleFrontiers in neurology

Short-term effect of Transcutaneous Spinal Cord Stimulation in patients with multiple sclerosis: a randomized sham-controlled crossover study.

Eira Lotta Spieker, Marie Hoffmann, Carolin Otto, Klemens Ruprecht, Lutz Harms, Thomas Schauer, Christina Salchow-Hömmen, Nikolaus Wenger

Abstract read
In one paragraph

Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Eira Lotta Spieker *Department of Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Marie Hoffmann *Department of Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Carolin OttoDepartment of Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Klemens RuprechtDepartment of Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Lutz HarmsDepartment of Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Thomas SchauerControl Systems Group, Technische Universität Berlin, Berlin, Germany.
Christina Salchow-HömmenDepartment of Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Nikolaus WengerDepartment of Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Gait deficits and leg spasticity are frequent symptoms in Primary and Secondary Progressive Multiple Sclerosis (PPMS and SPMS). Transcutaneous spinal cord stimulation (tSCS) may alleviate these symptoms through the reduction of spinal hyperexcitability. We conducted a single-center, randomized, sham-controlled clinical crossover study (German Clinical Trials Register: DRKS00023357, https://www.drks.de/search/en) in patients with PPMS and SPMS to assess the therapy effects of tSCS on spasticity and gait in the post stimulation period. Methods: Twenty participants were included in the study to receive tSCS and sham interventions on two separate study days in randomized order. Patients and examiners were blinded to the sequence allocation, which was performed using a quasi-randomized procedure to ensure balanced group sizes. The tSCS intervention consisted of biphasic pulses applied for 30 min at 50 Hz to lumbar spinal segments. Assessments were carried out before and immediately after each intervention. The primary outcome was defined as the Modified Ashworth Scale (MAS) sum score for bilateral leg spasticity. Secondary outcomes included unilateral MAS sum scores and clinical gait assessments. We used inertial sensors to monitor gait kinematics and EMG to record Posterior-Root-Muscle-Reflexes (PRM-reflex) in leg muscles. Results: Following the exclusion of two dropouts and two participants who did not reach the target intensity, sixteen participants, evenly distributed across the two intervention sequences, were included in the analysis. In comparison to sham, tSCS had a small effect on bilateral MAS sum score (effect size = -0.25, p = 0.12, CI: -5.67-0.63, for Generalized Equation Estimation), which didn't reach significance. More patients showed an improvement in stimulation condition (10 out of 16 patients) than in sham condition (7 out of 16 patients). We observed negligible effects of tSCS on clinical gait tests, kinematic parameters and PRM-reflex recruitment. Conclusion: Our results showed that tSCS had a small but no significant effect on spasticity. A reduction of spasticity did not immediately translate into an improvement of gait performance. Clinical trials registration: https://www.drks.de/search/en, identifier: DRKS00023357.

Indexed as

gaitprogressive multiple sclerosisrehabilitationspasticityTranscutaneous Spinal Cord Stimulation (tSCS)

Identifiers

PMID40917667
PMCPMC12408504

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.